Switch to:
Allergan PLC (NYSE:AGN)
EV/EBITDA
15.13 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Allergan PLC's enterprise value is $82,140 Mil. Allergan PLC's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2016 was $5,428 Mil. Therefore, Allergan PLC's EV/EBITDA ratio for today is 15.13.

AGN' s EV/EBITDA Range Over the Past 10 Years
Min: -224.1   Max: 386.1
Current: 15.15

-224.1
386.1

During the past 13 years, the highest EV/EBITDA Ratio of Allergan PLC was 386.10. The lowest was -224.10. And the median was 11.10.

AGN's EV/EBITDA is ranked higher than
59% of the 562 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 17.70 vs. AGN: 15.15 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Allergan PLC's stock price is $192.25. Allergan PLC's earnings per share for the trailing twelve months (TTM) ended in Sep. 2016 was $35.41. Therefore, Allergan PLC's P/E Ratio for today is 5.43.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Allergan PLC's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=82140.334/5428.1
=15.13

Allergan PLC's current Enterprise Value is $82,140 Mil.
Allergan PLC's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2016 was 1173.7 (Dec. 2015 ) + 1484 (Mar. 2016 ) + 1335.3 (Jun. 2016 ) + 1435.1 (Sep. 2016 ) = $5,428 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Allergan PLC's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=192.25/35.41
=5.43

Allergan PLC's share price for today is $192.25.
Allergan PLC's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2016 was -2.2 (Dec. 2015 ) + 0.47 (Mar. 2016 ) + -1.44 (Jun. 2016 ) + 38.58 (Sep. 2016 ) = $35.41.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Allergan PLC Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda -21.926.715.6310.4711.718.7218.2957.4188.6362.79

Allergan PLC Quarterly Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
ev2ebitda 22.6555.9788.63455.49174.14105.4462.7937.0932.4318.70
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK